Europe (WHO region) vs Republic of Moldova: Previously treated cases tested for RR-/MDR-TB

Europe (WHO region)
90.0%
in 2024
Republic of Moldova
100.0%
in 2024
Europe (WHO region) rank
2nd
Republic of Moldova rank
1st

Previously treated cases tested for RR-/MDR-TB over time

  • Europe (WHO region)
  • Republic of Moldova
020406080100200520142024

How they compare

Republic of Moldova currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.

That makes Republic of Moldova's figure about 1.1 times Europe (WHO region)'s.

The two have swapped places 4 times across 20 shared years of data; in 2005 it was Republic of Moldova ahead.

Europe (WHO region) ranks 2nd and Republic of Moldova ranks 1st of 11 groups.

Republic of Moldova has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Europe (WHO region) Republic of Moldova Difference Ahead
2000s 20.2% 62.6% 42.4% Republic of Moldova
2010s 57.7% 63.6% 5.9% Republic of Moldova
2020s 93.8% 97.2% 3.4% Republic of Moldova

Averages of every year both report within each decade.

Frequently asked questions

Which has higher previously treated cases tested for rr-/mdr-tb, Europe (WHO region) or Republic of Moldova?
Republic of Moldova, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
What is the difference in previously treated cases tested for rr-/mdr-tb between Europe (WHO region) and Republic of Moldova?
10.0%, with Republic of Moldova ahead.
How many years of comparable data are there for Europe (WHO region) and Republic of Moldova?
20 years are reported by both, from 2005 to 2024.
How do Europe (WHO region) and Republic of Moldova rank globally for previously treated cases tested for rr-/mdr-tb?
Europe (WHO region) ranks 2nd and Republic of Moldova ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe (WHO region) vs Republic of Moldova: Previously treated cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 11 September 2026, from https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/europe-who-region/moldova/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/previously-treated-cases-tested-for-rr-mdr-tb-percent/europe-who-region/moldova/">Europe (WHO region) vs Republic of Moldova: Previously treated cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed